The FDA has accepted Sanofi and Regeneron’s application to expand Dupixent’s use, with a decision expected by April 2025.

Regeneron (REGN) and Sanofi (SNY) announced that the FDA has accepted for review the resubmission of the supplemental Biologics License ...

Regeneron and Sanofi's Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a ...

The FDA last year turned away the companies' application and asked for additional efficacy data. Regeneron and Sanofi said the resubmission adds results from an additional Phase 3 study of Dupixent in ...

Angelina Jolie remains single since her 2016 split with Brad Pitt, as she is terrified of getting hurt again. Despite numerous suitors, she keeps them at a distance, fearing emotional pain.

DRESSED in a chic outfit, with her bright red lips in a glowing smile, Angelina Jolie looks happier and more confident than she has in years. After her very messy divorce from Brad Pitt ...

Dupixent (dupilumab) is a brand-name subcutaneous injection that’s prescribed for certain inflammatory conditions. Dupixent has interactions with some other drugs. Examples include certain ...

Angelina Jolie is returning to dramatic acting in a big fashion. The Hollywood icon is starring in "Maria," a film directed by Pablo Larrain where she plays the opera icon Maria Callas.

Eli Lilly (NYSE:LLY) said a Phase 3b study of its drug Ebglyss showed it was able to improve skin and itch in patients with moderate-to-severe atopic dermatitis who had previously been treated ...

Meanwhile, the company's Pharma segment generated €8.3B in sales with ~10% YoY growth as Dupixent sales rose ~22% YoY to €3.4B, prompting the company to reaffirm its €13B full-year sales ...

Sanofi reaffirms that Dupixent will deliver around 13 billion euros in 2024 sales. The company reported third-quarter sales of 13.44 billion euros or $14.79 billion, beating the consensus of $13. ...